Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for ...

The ASH expert panel agreed on 31 recommendations related to the treatment of VTE and superficial vein thrombosis, as well as diagnosis and thrombosis prophylaxis. Overall, there was a strong ...

At the dawn of the 21st century, venous thromboembolism (VTE) treatment remained in the dark ages. Backed by an MD and a legacy of paternalistic practice, we convinced patients to do what now seems ...

Thromboembol in blood vessel. Clot formation, 3D illustration Researchers sought to compare oral apixaban and subcutaneous dalteparin for treating patients with cancer-related venous thromboembolism.

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Updated clinical practice guidelines for the treatment and prevention of venous thromboembolism ...

This multicenter retrospective cohort study included adult patients with cancer diagnosed with venous thromboembolism (VTE) hospitalized in Thailand from 2017 to 2021. Anticoagulants were classified ...

Venous thromboembolism (VTE) is serious condition that begins with a blood clot in a vein – often in the lower leg – that makes its way to the lungs, causing a pulmonary embolism with potentially ...

Direct oral anticoagulants (DOACs) have transformed venous thromboembolism (VTE) treatment by offering predictable pharmacokinetics and eliminating routine monitoring requirements. Despite robust ...

Researchers sought to determine whether ABO blood type may impact the risk of developing VTE in patients with cancer. Some patients with cancer with a non-O blood type may be at an increased risk of ...

Anybody can develop a deep vein thrombosis (DVT). It's a serious public health issue. But some are more likely to get this clot – or even die from it – than others due to differences in treatment.

Please provide your email address to receive an email when new articles are posted on . Patients with venous thromboembolism treated with anticoagulants for more than 3 months had a lower risk for ...